Hematology

The Division of Hematology's major academic goal is to promote the understanding of a wide scope of hematological diseases. The diagnosis and management of these diseases require a broadly based knowledge in bone marrow physiology and biochemistry, tumor cell growth, hemostasis and thrombosis, red blood cell and hemoglobin molecular biology and immunology. The division has developed good collaboration with the departments of Pathology and Laboratory Medicine and Pharmacology in The University of Texas Medical School and The University of Texas M.D. Anderson Cancer Center. The interactions enhance research, teaching and patient activities.

The clinical program encompasses a comprehensive consultation service at Hermann Hospital, Lyndon Baines Johnson General Hospital (LBJGH), the M.D. Anderson Cancer Center (MDACC), and several specialized patient care services including a hemophilia treatment center and a hyperthermia cancer therapy program. The Division maintains outpatient clinics at Hermann Hospital and the LBJGH which provides care for a large number of patients with diversified hematologic and oncologic disorders. The Division sponsors several scheduled conferences, including a patient care conference, journal review club, interdepartmental cancer conference and specal research seminars given by invited speakers. The Center for Vascular and Thrombosis Research co-sponsors a joint blood conference attended by faculty, fellows, residents, and students. Furthermore, a number of outstanding conferences are offered on a regular basis at the MDACC.

Research in the division includes an interdepartmental program in vascular diseases, prostaglandin research, monocyte-macrophage physiology and biochemistry, clinical and laboratory hyperthermia, cell differentiation and platelet and endothelial cell function.